Maven Securities LTD Editas Medicine, Inc. Transaction History

Maven Securities LTD

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$39.27 - $72.94 $180,642 - $335,524	-4,600 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$31.29 - $56.64 $100,910 - $182,664	3,225 Added 234.55%	4,600 $263,000
Q1 2021 May 17, 2021	BUY	$39.71 - $90.58 $54,601 - $124,547	1,375 New	1,375 $58,000

226

54.3M

412K

355K

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $85.9M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

Stay updated on Maven Securities LTD with notifications on news.